Literature DB >> 25400729

CXCR6 deficiency attenuates pressure overload-induced monocytes migration and cardiac fibrosis through downregulating TNF-α-dependent MMP9 pathway.

Jia-Hong Wang1, Feng Su1, Shijun Wang2, Xian-Cheng Lu3, Shao-Heng Zhang4, De Chen4, Nan-Nan Chen4, Jing-Quan Zhong5.   

Abstract

An immerging role of TNF-α in collagen synthesis and cardiac fibrosis implies the significance of TNF-α production in the development of myocardial remodeling. Our previous study showed a reduction of TNF-α and attenuated cardiac remodeling in CXCR6 knockout (KO) mice after ischemia/reperfusion injury. However, the potential mechanism of TNF-α-mediated cardiac fibrosis with pressure overload has not been well elucidated. In the present study, we aim to investigate the role of CXCR6 in TNF-α release and myocardial remodeling in response to pressure overload. Pressure overload was performed by constriction of transverse aorta (TAC) surgery on CXCR6 KO mice and C57 wild-type (WT) counterparts. At 6 weeks after TAC, cardiac remodeling was assessed by echocardiography, cardiac TNF-α release and its type I receptor (TNFRI), were detected by ELISA and western blot, collagen genes Col1a1 (type I) and Col3a1 (type III) were examined by real-time PCR. Compared with CXCR6 WT mice, CXCR6 KO mice exhibited less cardiac dysfunction, reduced expression of TNFRI, Col1a1 and Col3a. In vitro, we confirmed that CXCR6 deficiency led to reduced homing and infiltration of CD11b(+) monocytes, which contributed to attenuated TNF-α release in myocardium. Furthermore, TNFRI antagonist pretreatment blocked AT1 receptor signaling and NOX4 expression, reduced collagen synthesis, and blunted the activity of MMP9 in CXCR6 WT mice after TAC, but these were not observed in CXCR6 KO mice. In the present work, we propose a mechanism that CXCR6 is essential for pressure overload-mediated myocardial recruitment of monocytes, which contributes to cardiac fibrosis through TNF-α-dependent MMP9 activation and collagen synthesis.

Entities:  

Keywords:  CXCR6; MMP9; TNF-α; cardiac fibrosis; pressure overload

Mesh:

Substances:

Year:  2014        PMID: 25400729      PMCID: PMC4230124     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  38 in total

1.  Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1.

Authors:  B Johnston; A R Burns; M Suematsu; T B Issekutz; R C Woodman; P Kubes
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

Review 2.  Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease.

Authors:  Christian Weber; Andreas Schober; Alma Zernecke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-08-19       Impact factor: 8.311

3.  Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques.

Authors:  Frank Tacke; David Alvarez; Theodore J Kaplan; Claudia Jakubzick; Rainer Spanbroek; Jaime Llodra; Alexandre Garin; Jianhua Liu; Matthias Mack; Nico van Rooijen; Sergio A Lira; Andreas J Habenicht; Gwendalyn J Randolph
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

4.  CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans.

Authors:  Michael Lehrke; Segan C Millington; Martina Lefterova; Reshmaal Gomes Cumaranatunge; Philippe Szapary; Robert Wilensky; Daniel J Rader; Mitchell A Lazar; Muredach P Reilly
Journal:  J Am Coll Cardiol       Date:  2007-01-12       Impact factor: 24.094

5.  TNF-alpha, but not IFN-gamma, regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: possible roles in the progression of renal fibrosis.

Authors:  Laurinda A Cooker; Darryl Peterson; Joann Rambow; Melisa L Riser; Rebecca E Riser; Feridoon Najmabadi; David Brigstock; Bruce L Riser
Journal:  Am J Physiol Renal Physiol       Date:  2007-03-20

6.  Pressure overload-induced transient oxidative stress mediates perivascular inflammation and cardiac fibrosis through angiotensin II.

Authors:  Hisashi Kai; Takahiro Mori; Keisuke Tokuda; Narimasa Takayama; Nobuhiro Tahara; Kiyoko Takemiya; Hiroshi Kudo; Yusuke Sugi; Daisuke Fukui; Hideo Yasukawa; Fumitaka Kuwahara; Tsutomu Imaizumi
Journal:  Hypertens Res       Date:  2006-09       Impact factor: 3.872

7.  Serum TGF-beta 1 and TNF-alpha levels and cardiac fibrosis in experimental chronic renal failure.

Authors:  Alexey V Fedulov; T P Ses; N A Gavrisheva; M G Rybakova; J G Vassilyeva; S B Tkachenko; A Kallner; J C MacMillan
Journal:  Immunol Invest       Date:  2005       Impact factor: 3.657

8.  Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state.

Authors:  Mei Sun; Manyin Chen; Fayez Dawood; Urszula Zurawska; Jeff Y Li; Thomas Parker; Zamaneh Kassiri; Lorrie A Kirshenbaum; Malcolm Arnold; Rama Khokha; Peter P Liu
Journal:  Circulation       Date:  2007-03-12       Impact factor: 29.690

9.  Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survival.

Authors:  Isabelle Vande Broek; Isabelle Van de Broek; Xavier Leleu; Rik Schots; Thiery Facon; Karin Vanderkerken; Ben Van Camp; Ivan Van Riet
Journal:  Haematologica       Date:  2006-02       Impact factor: 9.941

10.  Bone marrow derived cells are involved in the pathogenesis of cardiac hypertrophy in response to pressure overload.

Authors:  Jin Endo; Motoaki Sano; Jun Fujita; Kentaro Hayashida; Shinsuke Yuasa; Naoki Aoyama; Yuji Takehara; Osamu Kato; Shinji Makino; Satoshi Ogawa; Keiichi Fukuda
Journal:  Circulation       Date:  2007-08-13       Impact factor: 29.690

View more
  9 in total

1.  CXCR6 Mediates Pressure Overload-Induced Aortic Stiffness by Increasing Macrophage Recruitment and Reducing Exosome-miRNA29b.

Authors:  Shijun Wang; Jian Wu; Xuan Li; Rubin Tan; Liming Chen; Lifan Yang; Fangjie Dai; Leilei Ma; Lei Xu; Zhen Wang; Gang Zhao; Junbo Ge; Yunzeng Zou
Journal:  J Cardiovasc Transl Res       Date:  2022-08-26       Impact factor: 3.216

Review 2.  Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized trials in other fibrotic diseases.

Authors:  Si-Nan Lin; Ren Mao; Chenchen Qian; Dominik Bettenworth; Jie Wang; Jiannan Li; David H Bruining; Vipul Jairath; Brian G Feagan; Min-Hu Chen; Florian Rieder
Journal:  Physiol Rev       Date:  2021-09-27       Impact factor: 37.312

3.  Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers.

Authors:  Roni Allaoui; Caroline Bergenfelz; Sofie Mohlin; Catharina Hagerling; Kiarash Salari; Zena Werb; Robin L Anderson; Stephen P Ethier; Karin Jirström; Sven Påhlman; Daniel Bexell; Balázs Tahin; Martin E Johansson; Christer Larsson; Karin Leandersson
Journal:  Nat Commun       Date:  2016-10-11       Impact factor: 14.919

4.  Postnatal Growth Restriction in Mice Alters Cardiac Protein Composition and Leads to Functional Impairment in Adulthood.

Authors:  Joseph R Visker; Lawrence J Dangott; Eric C Leszczynski; David P Ferguson
Journal:  Int J Mol Sci       Date:  2020-12-12       Impact factor: 5.923

5.  Azithromycin Reduces Markers of Vascular Damage in Pediatric Patients With Sickle Cell Disease.

Authors:  Peter N Uchakin; Vishwas S Sakhalkar; Francis C Dane; Olga N Uchakina; Jatayah N Sheed; William T Uphouse; Om V Sakhalkar
Journal:  J Hematol       Date:  2021-07-28

6.  Obesity Correlates With Pronounced Aberrant Innate Immune Responses in Hospitalized Aged COVID-19 Patients.

Authors:  Michael Z Zulu; Suhas Sureshchandra; Amanda N Pinski; Brianna Doratt; Weining Shen; Ilhem Messaoudi
Journal:  Front Immunol       Date:  2021-10-11       Impact factor: 7.561

Review 7.  COVID-19, obesity, and immune response 2 years after the pandemic: A timeline of scientific advances.

Authors:  Mayara Belchior-Bezerra; Rafael Silva Lima; Nayara I Medeiros; Juliana A S Gomes
Journal:  Obes Rev       Date:  2022-07-15       Impact factor: 10.867

8.  Kinetic mRNA Profiling in a Rat Model of Left-Ventricular Hypertrophy Reveals Early Expression of Chemokines and Their Receptors.

Authors:  Simona Nemska; Laurent Monassier; Max Gassmann; Nelly Frossard; Reza Tavakoli
Journal:  PLoS One       Date:  2016-08-15       Impact factor: 3.240

9.  Association of soluble interleukin-2 receptor α and tumour necrosis factor receptor 1 with heart failure: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Hooman Bakhshi; Vinithra Varadarajan; Bharath Ambale-Venkatesh; Zahra Meyghani; Mohammad R Ostovaneh; Peter Durda; Colin O Wu; Russell P Tracy; Mary Cushman; David A Bluemke; João A C Lima
Journal:  ESC Heart Fail       Date:  2020-03-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.